Estrogen Plus Progestin, Benefits and Risks: The “Women’s Health Initiative” Trials | Citedby Results | American Journal of Critical Care | American Association of Critical-Care Nurses

Skip to Main Content

Skip Nav Destination

Estrogen Plus Progestin, Benefits and Risks: The “Women’s Health Initiative” Trials

Am J Crit Care (2005) 14 (2): 157–160.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype

Xuezheng Sun
Hazel B. Nichols
Chiu-Kit Tse
Mary B. Bell
Whitney R. Robinson
Mark E. Sherman
Andrew F. Olshan
Melissa A. Troester

Cancer Epidemiology, Biomarkers & Prevention (2016) 25 (1): 60.

Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer

Eryn B. Callihan
Dexiang Gao
Sonali Jindal
Traci R. Lyons
Elizabeth Manthey
Susan Edgerton
Alexander Urquhart
Pepper Schedin
Virginia F. Borges

Breast Cancer Research and Treatment (2013) 138 (2): 549.

Synthesis and Biological Evaluation of Heterocyclic Ring-Fused Betulinic Acid Derivatives as Novel Inhibitors of Osteoclast Differentiation and Bone Resorption

Jun Xu
Zhenxi Li
Jian Luo
Fan Yang
Ting Liu
Mingyao Liu
Wen-Wei Qiu
Jie Tang

Journal of Medicinal Chemistry (2012) 55 (7): 3122.

Effect of Black Cohosh on Genital Atrophy and Its Adverse Effect in Postmenopausal Women

Sung Nam Hong
Jin Ha Kim
Heung Yeol Kim
Ari Kim

The Journal of Korean Society of Menopause (2012) 18 (2): 106.

Improving sleep quality in climacteric women with insomnia: A randomized, head-to-head trial between Jia-Wei-Shiau-Yau San (JWSYS) and Suan-Zao-Ren Tang (SZRT)

Hsien-Chang Wu
Yen-Hui Chen
Jung-Nien Lai
Jing-Shiang Hwang
Jung-Der Wang

European Journal of Integrative Medicine (2011) 3 (3): e143.

Current awareness: Pharmacoepidemiology and drug safety

Pharmacoepidemiology and Drug Safety (2005) 14 (10): i.